Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Short Interest Up 369.2% in July

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 29,285 shares, an increase of 369.2% from the July 15th total of 6,242 shares. Based on an average daily volume of 21,150 shares, the short-interest ratio is currently 1.4 days. Currently, 0.0% of the shares of the company are short sold.

Spectral Diagnostics Price Performance

OTCMKTS EDTXF opened at $1.00 on Wednesday. The stock has a market capitalization of $295.02 million, a price-to-earnings ratio of -10.05 and a beta of 0.13. Spectral Diagnostics has a 1-year low of $0.59 and a 1-year high of $1.31. The business’s fifty day moving average price is $0.97 and its 200-day moving average price is $0.98.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.